0001513162-13-000271.txt : 20130408 0001513162-13-000271.hdr.sgml : 20130408 20130408161930 ACCESSION NUMBER: 0001513162-13-000271 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130402 ITEM INFORMATION: Entry into a Material Definitive Agreement ITEM INFORMATION: Termination of a Material Definitive Agreement FILED AS OF DATE: 20130408 DATE AS OF CHANGE: 20130408 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIOMERICA INC CENTRAL INDEX KEY: 0000073290 STANDARD INDUSTRIAL CLASSIFICATION: DENTAL EQUIPMENT & SUPPLIES [3843] IRS NUMBER: 952645573 STATE OF INCORPORATION: DE FISCAL YEAR END: 0531 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-08765 FILM NUMBER: 13748603 BUSINESS ADDRESS: STREET 1: 17571 VON KARMAN AVENUE CITY: IRVINE STATE: CA ZIP: 92614 BUSINESS PHONE: 9496452111 MAIL ADDRESS: STREET 1: 17571 VON KARMAN AVENUE CITY: IRVINE STATE: CA ZIP: 92614 FORMER COMPANY: FORMER CONFORMED NAME: NMS PHARMACEUTICALS INC DATE OF NAME CHANGE: 19871130 FORMER COMPANY: FORMER CONFORMED NAME: NUCLEAR MEDICAL SYSTEMS INC DATE OF NAME CHANGE: 19830216 FORMER COMPANY: FORMER CONFORMED NAME: NUCLEAR INSTRUMENTS INC DATE OF NAME CHANGE: 19720508 8-K 1 biomerica8k4213final.htm FORM 8-K FORM 8-K

SECURITIES AND EXCHANGE COMMISSION


WASHINGTON, D.C.


FORM 8-K


CURRENT REPORT



Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934



_____             April 2, 2013__________

Date of Report (date of earliest event reported)



BIOMERICA, INC.

(Exact Name of Registrant as Specified in its Charter)

 

          Delaware 0-8765 95-2645573
(State or Other (Commission (IRS Employer
Jurisdiction of File Number) Identification Number)
Incorporation)

 

17571 Von Karman Ave.

Irvine, California 92614

(Address of Principal Executive Offices

Including Zip Code)



949-645-2111

(Registrant’s Telephone Number,

Including Area Code)


______________

(Former Name or Former Address if Changed

Since Last Report)


Page 1 of 2 pages






Item 1.01.

Entry into a Material Definitive Agreement



On April 2, 2013, Biomerica, Inc. ("Biomerica" or the "Company") entered into a new exclusive distribution agreement and a First Amendment thereto with a new distributor in China (the “New Distribution Agreement”). The New Distribution Agreement has a three year term and covers the Company’s GAD, ICA, IAA and certain food intolerance products for the China market. The terms of the New Distribution Agreement are similar to the former distribution agreement entered into with the Company’s former China distributor which was terminated as described in Item 1.02 below (the “Prior Distribution Agreement”).  The New Distribution Agreement provides for greater minimum sales volumes than were in the Company’s Prior Distribution Agreement.



Item 1.02.

Termination of Material Definitive Agreement.


On April 2, 2013, prior to entering into the New Distribution Agreement described in Item 1.01 above, the Company terminated its existing exclusive Prior Distribution Agreement with its distributor in China. At the time of the termination of the Prior Distribution Agreement, there was no accounts receivable due from the prior distributor.












SIGNATURES


     Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


Dated:  April 8, 2013

                        Biomerica, Inc.


            By: /s/ Zackary S. Irani

Zackary S. Irani

Chief Executive Officer